Changing Pathologic Nomenclature to Change Clinical Behavior

Дата публикации: 01-07-2026 00:00:00

Vickers and colleagues have modeled the effects of relabeling grade group 1 or Gleason 3 + 3 prostate cancer as a precancerous condition. Using a number of scenarios, they find that by reducing risk of unnecessarily aggressive treatment, more men will agree to prostate screening, leading to the diagnosis of more men with aggressive disease and more prostate cancer deaths being averted. One should note that the scenarios assume that prostate cancer screening and treatment reduces prostate cancer mortality and that quality screening and treatment is widely available.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Half of prostate cancer focal therapy use found to fall outside current guideline-supported groups	0	7.2	13-08-2026
2	Researchers develop mathematical measures to better personalize therapy for prostate cancer	0	7.4	13-08-2026
3	For early prostate cancer, 'active surveillance' is now the number 1 choice	0	9.98	13-08-2026
4	Race, Secondary Treatment, and Survival in Localized Prostate Cancer	0	5.24	21-07-2026
5	Комбинированная терапия снизила риск гибели от тяжелых форм рака простаты на 40%	0	0	19-10-2025
6	Prostate cancer treatment given to thousands of UK men piles on the pounds and increases risk of heart problems, study finds	0	5.63	13-08-2026
7	Experimental treatment kills prostate tumor cells while reawakening antitumor immunity	0	8.19	15-06-2026
8	AI-guided outreach increased cancer screenings and reduced mortality, new study finds	5	8	07-07-2026
9	Del diagnóstico precoz a la medicina de precisión: el cáncer de próstata gana batalla y tiempo de vida a los hombres	0	7	10-06-2026
10	Caution in Interpreting Survival After for Salvage Focal Therapy vs Salvage Radical Prostatectomy—Reply	0	7.28	01-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 6.46. Источник: jamanetwork.com.